Ask Well: Do Monogamous Women Still Need a Pap Smear?
Most cases of cervical cancer are linked with the sexually transmitted HPV virus. So why are monogamous women who test negative for HPV still given pap smears? (Source: NYT Health)
Source: NYT Health - June 9, 2014 Category: Consumer Health News Authors: By TARA PARKER-POPE Tags: Ask Well Body medicine and health Featured Tests (Medical) Human Papillomavirus (HPV) Source Type: news
Ask Well: Do Monogamous Women Still Need a Pap Smear?
Most cases of cervical cancer are linked with the sexually transmitted HPV virus. So why are monogamous women who test negative for HPV still given pap smears? (Source: NYT)
Source: NYT - June 9, 2014 Category: American Health Authors: By TARA PARKER-POPE Tags: Ask Well Body medicine and health Featured Tests (Medical) Human Papillomavirus (HPV) Source Type: news
A new way to screen for cervical cancer
In April, the FDA approved the use of a new human papillomavirus test for primary cervical cancer screening. Aaron Ermel, M.D., discusses the newly approved test, the reasons it should not be used in women under 25 and the impact this test will have on cervical cancer screenings in the future.
Sydney Spiesel, M.D., Ph.D., joins Dr. Ermel to discuss why parents may be reluctant to vaccinate the.... (Source: Sound Medicine)
Source: Sound Medicine - June 1, 2014 Category: Global & Universal Authors: Sound Medicine Source Type: news
Low-Dose Radiation Okay in Some HPV Head and Neck CancersLow-Dose Radiation Okay in Some HPV Head and Neck Cancers
Oropharyngeal cancer patients who test positive for human papillomavirus could be treated with lower than standard doses of radiation, suggest results from a phase 2 study. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 30, 2014 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Consumer Information on: cobas® HPV Test - P100020S008
It is the first human papillomavirus (HPV) test for primary cervical cancer screening. The cobas HPV Test is used to identify HPV DNA from 14 high-risk genital HPV types that are commonly associated with cervical cancer. (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - May 1, 2014 Category: Medical Equipment Source Type: news
HPV Test for Primary Cervical Cancer Screening
FDA Approves First Human Papillomavirus Test for Primary Cervical Cancer Screening (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 29, 2014 Category: Journals (General) Source Type: news
FDA Approves Roche's HPV Test For First-Line Primary Screening For Cervical Cancer
Roche announced recently that the U.S. Food and Drug Administration (FDA) approved the cobas HPV (Human Papillomavirus) Test for use as a first-line primary screening test for cervical cancer in women 25 and older. (Source: Medical Design Online News)
Source: Medical Design Online News - April 28, 2014 Category: Medical Equipment Source Type: news
FDA Appoves First Human Papillomavirus Test for Primary Cervical Cancer Screening
Source: Food and Drug Administration
Related MedlinePlus Pages: Cervical Cancer, HPV (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - April 25, 2014 Category: Consumer Health News Source Type: news
FDA Approves Roche's HPV Test for First-Line Primary Screening for Cervical Cancer
Roche announced today that the U.S. Food and Drug Administration (FDA) approved the cobas HPV (Human Papillomavirus) Test for use as a first-line primary screening test for cervical cancer in women 25 and older. The approval follows the March 12 unanimous recommendation from the Microbiology Devices Panel of the FDA’s Medical Devices Advisory Committee, making the cobas HPV Test the first and only HPV test in the United States approved for first-line primary screening. (Source: Roche Investor Update)
Source: Roche Investor Update - April 25, 2014 Category: Pharmaceuticals Source Type: news
FDA Approves Roche's HPV Test for First-Line Primary Screening for Cervical Cancer
Roche announced today that the U.S. Food and Drug Administration (FDA) approved the cobas HPV (Human Papillomavirus) Test for use as a first-line primary screening test for cervical cancer in women 25 and older. The approval follows the March 12 unanimous recommendation from the Microbiology Devices Panel of the FDA’s Medical Devices Advisory Committee, making the cobas HPV Test the first and only HPV test in the United States approved for first-line primary screening. (Source: Roche Media News)
Source: Roche Media News - April 25, 2014 Category: Pharmaceuticals Source Type: news
FDA: DNA Test Can Replace Pap Test
WASHINGTON (MedPage Today) -- The FDA has approved a molecular test for human papillomavirus DNA as a first-line, stand-alone screen for cervical cancer. (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 25, 2014 Category: Hematology Source Type: news
First HPV Test Approved for Primary Cervical Screening (FREE)
By the Editors
The FDA has approved the first human papillomavirus DNA test for women aged 25 and older that can be used … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - April 25, 2014 Category: Primary Care Source Type: news
Primary HPV screening offers important new option for cervical cancer detection, prevention
New options for detecting and preventing cervical cancer have been welcomed recently into the scientific community, including the primary human papillomavirus (HPV) testing recently approved by the FDA. Primary HPV testing does not replace the Pap test, and it is extremely unlikely that doctors will stop using the Pap any time soon. However, FDA approval of primary HPV testing means the HPV test can be used first when screening a woman for cervical cancer. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 24, 2014 Category: Science Source Type: news
FDA approves first human papillomavirus test for primary cervical cancer screening
The U.S. Food and Drug Administration today approved the first FDA-approved HPV DNA test for women 25 and older that can be used alone to help a health care professional assess the need for a woman to undergo additional diagnostic testing for cervical cancer. The test also can provide information about the patient’s risk for developing cervical cancer in the future. (Source: Food and Drug Administration)
Source: Food and Drug Administration - April 24, 2014 Category: American Health Source Type: news
Genomic Study Reveals Role of Human Papillomavirus in Cervical Cancer and Identifies Novel Therapeutic Targets for the Disease
Findings may help physicians tailor cervical cancer therapies to specific gene mutations and improve the accuracy of diagnostic screening tests for this disease New scientific knowledge about the role of human papillomavirus (HPV) in the growth of cervical cancer is creating excitement within the medical community. Among other things, these findings could encourage more widespread […] (Source: Dark Daily)
Source: Dark Daily - April 23, 2014 Category: Laboratory Medicine Authors: jude Tags: Digital Pathology Instruments & Equipment Laboratory Management and Operations Laboratory News Laboratory Operations Laboratory Pathology Broad Institute cervical cancer cervical squamous cell carcinoma clinical laboratory cytopatholog Source Type: news
